Form 4: Intapp Director Ralph Baxter Executes Option and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Director Ralph Baxter exercised stock options and sold shares of Intapp, Inc. common stock according to a pre-arranged 10b5-1 trading plan.
Summary
- On October 10, 2024, Ralph Baxter, a director of Intapp, Inc., exercised options to acquire 5,000 shares of common stock at a price of $3.99 per share.
- Concurrently, Baxter sold 600 shares at a weighted average price of $46.7355 and 4,400 shares at a weighted average price of $47.5411.
- These transactions were executed under a 10b5-1 trading plan established on November 27, 2023.
- Following these transactions, Baxter directly owns 5,624 shares of Intapp, Inc. common stock and holds options for 70,261 shares.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The filing simply reports transactions under a pre-existing plan, indicating routine activity rather than a significant event.
Positives
- The transactions were executed under a pre-arranged 10b5-1 trading plan, which is generally viewed as a transparent and compliant method for insiders to trade company stock.
Industry Context
Insider transactions are common and closely monitored, with 10b5-1 plans providing a structured way for insiders to trade without concerns about trading on non-public information. The filing provides transparency into the trading activities of a company director.
Comparison to Industry Standards
- Comparing Ralph Baxter's transactions to other directors in similar SaaS companies would require analyzing their Form 4 filings for similar periods.
- A typical benchmark would be to assess the percentage of shares sold relative to their total holdings and option grants.
- Analyzing the timing of these transactions relative to earnings announcements or other material events would also be relevant.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the sale of shares, but the existence of a 10b5-1 plan mitigates concerns about insider trading.
Key Dates
| Date | Description |
|---|---|
| November 27, 2023 | Date the 10b5-1 plan was put in place by the Reporting Person |
| October 10, 2024 | Date of the option exercise and sale of shares |
| May 10, 2026 | Expiration date of the Employee Stock Option |
| October 11, 2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.